Vanrx Pharmasystems’ Microcell Vial Filler was hand-picked by industry magazine Pharmaceutical Manufacturing for a 2018 Pharma Innovation Award. This is the second award presented in 2018 for the Microcell, following its Interphex ‘Best in show’ award in April.
In March 2018, data from surveys presented at ISPE Aseptic and PDA Annual Meeting provides important insights into aseptic filling methods. Pharma companies state that there are significant obstacles to adopt isolators or RABS. Vanrx suggests that these obstacles are avoided by adopting fully robotic gloveless isolators.
In 2010, our CEO Chris Procyshyn ‘wrote the book’ on the use of robotics in pharmaceutical manufacturing. In this blog, we look at his chapter “Isolated Robotics” in the publication Advanced Aseptic Processing Technology and review where Vanrx stands today on the use of robotics.
Industry magazines Pharmaceutical Manufacturing and Pharmaceutical Technology recently published articles about smarter contamination control and current aseptic filling challenges. Vanrx is featured in both articles, providing our perspective to help manufacturing leaders navigate the current landscape.
Vanrx recently hosted its first User Group meeting, with customers and members of the Matrix Alliance partnership, coming to Whistler for two days of collaborative discussion. The goal being to share information and strategies regarding the implementation of Vanrx’s Aseptic Filling Workcells.
Fujifilm Diosynth has expanded its fill/finish capabilities for late stage and commercial gene therapies and viral vaccines using Vanrx's SA25 Aseptic Filling Workcell. The SA25 will be installed at Fujifilm’s biomanufacturing facility in College Station, Texas.